» Articles » PMID: 37535577

Point-of-care PCR Testing of SARS-CoV-2 in the Emergency Department: Influence on Workflow and Efficiency

Overview
Journal PLoS One
Date 2023 Aug 3
PMID 37535577
Authors
Affiliations
Soon will be listed here.
Abstract

Problem: Regarding transmissible viral diseases such as those caused by SARS-CoV-2 virus, one of the key challenges is isolation management until final diagnosis. This study investigates the influence of SARS-CoV-2 point-of-care (POC) PCR on workflow and efficiency in an emergency department (ED) of a tertiary university hospital.

Method: An analysis of 17,875 ED patients receiving either SARS-CoV-2 POC PCR (rapid PCR, 11,686 patients) or conventional laboratory SARS-CoV-2 PCR (conventional PCR, 6,189 patients) was performed. The pathways for both groups were mapped and compared, and process times from admission to diagnosis were measured. Effects on resource management within the ED were quantified. Direct costs due to isolation, loss of capacities, and revenues were calculated for inpatients.

Results: The mean time from admission to result was 1.62 h with rapid PCR and 16.08 h with conventional PCR (p < 0.01), reducing the isolation time by 14.46 h. In the first 2 h after testing, test results were available for > 75% of the rapid PCR group and none of the conventional PCR group. Ninety percent of the results were available within 3 h for the rapid PCR and within 21 h for the conventional PCR group. For the conventional PCR group, an increase in direct costs of €35.74 and lost revenues of €421.06 for each inpatient case was detected.

Conclusion: Rapid PCR significantly reduces the time-to-results and time for isolation relative to conventional PCR. Although testing costs for rapid PCR are higher, it benefits workflow, reduces total costs, and frees up ward capacity.

Citing Articles

Key Insights into Respiratory Virus Testing: Sensitivity and Clinical Implications.

Garcia-Rodriguez J, Janvier F, Kill C Microorganisms. 2025; 13(1).

PMID: 39858831 PMC: 11767719. DOI: 10.3390/microorganisms13010063.


Impact of Point-of-Care Testing on Diagnosis, Treatment, and Surveillance of Vaccine-Preventable Viral Infections.

Lakshmanan K, Liu B Diagnostics (Basel). 2025; 15(2).

PMID: 39857007 PMC: 11763637. DOI: 10.3390/diagnostics15020123.


Understanding the species and their challenges to animal health and livestock species for informed development of new, specific treatment strategies.

Rideout H, Cook A, Whetton A Front Parasitol. 2025; 3():1448076.

PMID: 39817173 PMC: 11732131. DOI: 10.3389/fpara.2024.1448076.


Clinical impact of rapid molecular diagnostic tests in patients presenting with viral respiratory symptoms: A systematic literature review.

Mojebi A, Wu P, Keeping S, Hale B, Chase J, Beaubrun A PLoS One. 2024; 19(6):e0303560.

PMID: 38870136 PMC: 11175541. DOI: 10.1371/journal.pone.0303560.


Impact of the early phase of the COVID-19 pandemic on emergency department-to-intensive care unit admissions in Korea: an interrupted time-series analysis.

Lee K, Han C, Min H, Lee J, Youn S, Kim Y BMC Emerg Med. 2024; 24(1):51.

PMID: 38561666 PMC: 10985913. DOI: 10.1186/s12873-024-00968-1.

References
1.
Hong K, Lee S, Kim T, Huh H, Lee J, Kim S . Guidelines for Laboratory Diagnosis of Coronavirus Disease 2019 (COVID-19) in Korea. Ann Lab Med. 2020; 40(5):351-360. PMC: 7169629. DOI: 10.3343/alm.2020.40.5.351. View

2.
Holzner C, Pabst D, Anastasiou O, Dittmer U, Manegold R, Risse J . SARS-CoV-2 rapid antigen test: Fast-safe or dangerous? An analysis in the emergency department of an university hospital. J Med Virol. 2021; 93(9):5323-5327. PMC: 8242658. DOI: 10.1002/jmv.27033. View

3.
Verelst F, Kuylen E, Beutels P . Indications for healthcare surge capacity in European countries facing an exponential increase in coronavirus disease (COVID-19) cases, March 2020. Euro Surveill. 2020; 25(13). PMC: 7140594. DOI: 10.2807/1560-7917.ES.2020.25.13.2000323. View

4.
Ganesh B, Rajakumar T, Malathi M, Manikandan N, Nagaraj J, Santhakumar A . Epidemiology and pathobiology of SARS-CoV-2 (COVID-19) in comparison with SARS, MERS: An updated overview of current knowledge and future perspectives. Clin Epidemiol Glob Health. 2021; 10:100694. PMC: 7806455. DOI: 10.1016/j.cegh.2020.100694. View

5.
Fistera D, Hartl A, Pabst D, Manegold R, Holzner C, Taube C . What about the others: differential diagnosis of COVID-19 in a German emergency department. BMC Infect Dis. 2021; 21(1):969. PMC: 8446739. DOI: 10.1186/s12879-021-06663-x. View